Tekla Life Company Leadership
| HQL Stock | USD 13.43 0.21 1.54% |
About 75 percent of all Tekla Life's insiders are aggressively buying. The analysis of insiders' sentiment of trading Tekla Life Sciences stock suggests that many insiders are very bullish at this time. Tekla Life employs about 11 people. The company is managed by 11 executives with a total tenure of roughly 123 years, averaging almost 11.0 years of service per executive, having 1.0 employees per reported executive.
| Oleg Pohotsky Chairman Independent Chairman of the Board of Trustees |
| Daniel Omstead President Principal Executive Officer and President Trustee and Member of Valuation Committee |
Insider Sentiment 75
Mostly Buying
Selling | Buying |
Latest Trades
| 2025-02-12 | Saba Capital Management, L.P. | Disposed 36536 @ 13.75 | View | ||
| 2025-02-10 | Saba Capital Management, L.P. | Disposed 42987 @ 13.95 | View | ||
| 2025-02-03 | Saba Capital Management, L.P. | Disposed 1846 @ 14.03 | View | ||
| 2025-01-31 | Saba Capital Management, L.P. | Disposed 15143 @ 14.27 | View | ||
| 2025-01-29 | Saba Capital Management, L.P. | Disposed 11674 @ 14.12 | View | ||
| 2024-08-23 | Bill Maher | Acquired 650 @ 15.37 | View | ||
| 2024-07-16 | Rose Dimartino | Acquired 1000 @ 15.53 | View | ||
| 2024-06-26 | Saba Capital Management, L.P. | Acquired 100 @ 14.07 | View | ||
| 2024-06-24 | Saba Capital Management, L.P. | Acquired 13812 @ 14.08 | View | ||
| 2024-06-12 | Saba Capital Management, L.P. | Acquired 2400 @ 13.88 | View | ||
| 2024-06-10 | Saba Capital Management, L.P. | Acquired 9704 @ 13.71 | View | ||
| 2024-06-06 | Saba Capital Management, L.P. | Acquired 9598 @ 13.8 | View | ||
| 2024-06-04 | Saba Capital Management, L.P. | Acquired 33357 @ 13.5 | View | ||
| 2024-05-30 | Saba Capital Management, L.P. | Acquired 669 @ 13.05 | View | ||
| 2024-05-28 | Saba Capital Management, L.P. | Acquired 8714 @ 13.38 | View | ||
| 2024-05-23 | Saba Capital Management, L.P. | Acquired 1303 @ 13.5 | View | ||
| 2024-05-15 | Saba Capital Management, L.P. | Acquired 34755 @ 14.19 | View | ||
| 2024-05-10 | Saba Capital Management, L.P. | Acquired 57862 @ 13.86 | View | ||
| 2024-05-08 | Saba Capital Management, L.P. | Acquired 10986 @ 13.7 | View | ||
| 2024-05-06 | Saba Capital Management, L.P. | Acquired 10713 @ 13.62 | View |
Monitoring Tekla Life's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Tekla |
Tekla Life Management Team Effectiveness
At this time, Tekla Life's Return On Tangible Assets are quite stable compared to the past year. Return On Assets is expected to rise to 0.18 this year, although the value of Return On Capital Employed is projected to rise to (0.01). At this time, Tekla Life's Non Currrent Assets Other are quite stable compared to the past year. Return On Tangible Assets is expected to rise to 0.18 this year, although the value of Non Current Assets Total will most likely fall to about 339.8 M. Tekla Life's management efficiency ratios could be used to measure how well Tekla Life manages its routine affairs as well as how well it operates its assets and liabilities.The value of Common Stock Shares Outstanding is expected to slide to about 19.7 M. Net Loss is expected to rise to about (89.4 M) this year
Tekla Life Workforce Comparison
Tekla Life Sciences is currently under evaluation in number of employees category among its peers. The total workforce of Financials industry is currently estimated at about 220. Tekla Life adds roughly 0.0 in number of employees claiming only tiny portion of equities under Financials industry.
The company has Net Profit Margin of 21.43 %, which may imply that it executes well on its competitive polices and has reasonable control over its expenses and variable costs. This is very large. In the same way, it shows Net Operating Margin of (0.66) %, which entails that for every $100 of revenue, it lost $0.66. Tekla Life Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Tekla Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Tekla Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Tekla Life insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2024-06-01 | 32.0 | 32 | 1 | 817,589 | 0.00 |
| 2014-06-01 | 1.1667 | 7 | 6 | 18,753 | 52,759 |
| 2007-12-01 | 1.0 | 1 | 1 | 1,500 | 2,000 |
Tekla Life Notable Stakeholders
A Tekla Life stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Tekla Life often face trade-offs trying to please all of them. Tekla Life's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Tekla Life's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Oleg Pohotsky | Independent Chairman of the Board of Trustees | Profile | |
| Dr MS | President Officer | Profile | |
| Daniel Omstead | Principal Executive Officer and President Trustee and Member of Valuation Committee | Profile | |
| Thomas Kent | Independent Trustee | Profile | |
| William Reardon | Independent Trustee | Profile | |
| Elizabeth Nabel | Independent Trustee | Profile | |
| Laura Woodward | Chief Compliance Officer, Treasurer, Secretary | Profile | |
| Peter Branner | Chief Officer | Profile | |
| Lucinda Stebbins | Independent Trustee | Profile | |
| Jeffrey Bailey | Independent Trustee | Profile | |
| Rakesh Jain | Independent Trustee | Profile |
About Tekla Life Management Performance
The success or failure of an entity such as Tekla Life Sciences often depends on how effective the management is. Tekla Life management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Tekla management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Tekla management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.17 | 0.18 | |
| Return On Capital Employed | (0.01) | (0.01) | |
| Return On Assets | 0.17 | 0.18 | |
| Return On Equity | 0.17 | 0.18 |
Tekla Life Workforce Analysis
Traditionally, organizations such as Tekla Life use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Tekla Life within its industry.Tekla Life Manpower Efficiency
Return on Tekla Life Manpower
| Revenue Per Employee | 7.9M | |
| Revenue Per Executive | 7.9M | |
| Net Income Per Employee | 7.8M | |
| Net Income Per Executive | 7.8M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Life. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.425 | Dividend Share 1.66 | Earnings Share 3.04 | Revenue Per Share | Quarterly Revenue Growth 0.07 |
The market value of Tekla Life Sciences is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Life's value that differs from its market value or its book value, called intrinsic value, which is Tekla Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Life's market value can be influenced by many factors that don't directly affect Tekla Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.